Two members of Alabama’s congressional delegation on Tuesday criticized the FDA’s recent approval of a new generic abortion pill.

The FDA’s recent approval of a new generic abortion drug “endangers women’s health, according to U.S. Rep. Robert Aderholt (R-Haleyville).

Aderholt said on Tuesday, "The FDA’s approval of a new generic version of the abortion pill, mifepristone, endangers women’s health and disregards the value of life. Previously approved versions of this drug demonstrated dangerous side effects including life-threatening sepsis, infection and hemorrhaging.”

“The FDA’s own fact sheet on mifepristone shows troubling rates of adverse events including hospitalization, blood transfusions, and even death following use of this dangerous drug," he added. "Even more troubling,

See Full Page